Where is Abbott Laboratories's long-term debt disclosed?
The figure, the filing and period it comes from, and the reported definition.
The answer
$12.93B
Long-term debt, as of Dec 31, 2025
Document: 10-K filed 2026-02-20 (accession 0001628280-26-010185)
Reported as XBRL element LongTermDebt (Long-term Debt).
Definition: Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
Calculation: none — the value is reported directly.
Source register
| Period end | Value | Form | Filed | Accession |
|---|---|---|---|---|
| Dec 31, 2018 | $19.37B | 10-K | 2020-02-21 | 0001104659-20-023904 |
| Dec 31, 2019 | $17.94B | 10-K | 2021-02-19 | 0001104659-21-025751 |
| Dec 31, 2020 | $18.53B | 10-K | 2022-02-18 | 0001104659-22-025141 |
| Dec 31, 2021 | $18.05B | 10-K | 2023-02-17 | 0001628280-23-004026 |
| Dec 31, 2022 | $16.77B | 10-K | 2024-02-16 | 0001628280-24-005348 |
| Dec 31, 2023 | $14.68B | 10-K | 2025-02-21 | 0001628280-25-007110 |
| Dec 31, 2024 | $14.13B | 10-K | 2026-02-20 | 0001628280-26-010185 |
| Dec 31, 2025 | $12.93B | 10-K | 2026-02-20 | 0001628280-26-010185 |